BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9761118)

  • 1. Chromosome 5 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Kemp BL; Amos CI; Siciliano MJ; Spitz MR
    Int J Cancer; 1998 Oct; 79(5):490-3. PubMed ID: 9761118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of cells with bleomycin-induced chromosomal lesions in the cultured lymphocytes of lung cancer patients.
    Wu XF; Spitz MR; Delclos GL; Connor TH; Zhao Y; Siciliano MJ; Hsu TC
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):527-32. PubMed ID: 8827357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer.
    Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR
    Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case-control analysis of lymphocytic chromosome 9 aberrations in lung cancer.
    Zhu Y; Spitz MR; Strom S; Tomlinson GE; Amos CI; Minna JD; Wu X
    Int J Cancer; 2002 Dec; 102(5):536-40. PubMed ID: 12432559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer cases.
    Wu X; Hsu TC; Annegers JF; Amos CI; Fueger JJ; Spitz MR
    Cancer Res; 1995 Feb; 55(3):557-61. PubMed ID: 7530597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleomycin-induced chromosome breaks as a risk marker for lung cancer: a case-control study with population and hospital controls.
    Zheng YL; Loffredo CA; Yu Z; Jones RT; Krasna MJ; Alberg AJ; Yung R; Perlmutter D; Enewold L; Harris CC; Shields PG
    Carcinogenesis; 2003 Feb; 24(2):269-74. PubMed ID: 12584177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions.
    Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR
    Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers.
    Abdel-Rahman SZ; El-Zein RA; Zwischenberger JB; Au WW
    Mutat Res; 1998 Feb; 398(1-2):43-54. PubMed ID: 9626964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung carcinoma patients with a family history of cancer and lymphocyte primary chromosome 9 aberrations.
    Wu X; Dave BJ; Jiang H; Pathak S; Spitz MR
    Cancer; 1997 Apr; 79(8):1527-32. PubMed ID: 9118034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis.
    Dave BJ; Hopwood VL; King TM; Jiang H; Spitz MR; Pathak S
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):743-9. PubMed ID: 8672991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome aberrations in peripheral blood lymphocytes of lung cancer patients exposed to radon and air pollution.
    Minina VI; Sinitsky MY; Druzhinin VG; Fucic A; Bakanova ML; Ryzhkova AV; Savchenko YA; Timofeeva AA; Titov RA; Voronina EN; Volobaev VP; Titov VA
    Eur J Cancer Prev; 2018 Jan; 27(1):6-12. PubMed ID: 27232209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-radiation-induced single cell DNA damage as a measure of susceptibility to lung cancer: a preliminary report.
    Zhang H; Buchholz TA; Hancock D; Spitz MR; Wu X
    Int J Oncol; 2000 Aug; 17(2):399-404. PubMed ID: 10891553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome aberrations as a predictor of clinical outcome for smoking associated lung cancer.
    El-Zein R; Abdel-Rahman SZ; Conforti-Froes N; Alpard SK; Zwischenberger JB
    Cancer Lett; 2000 Sep; 158(1):65-71. PubMed ID: 10940511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer.
    Wei Q; Gu J; Cheng L; Bondy ML; Jiang H; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(17):3975-9. PubMed ID: 8752166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome alterations in human small cell lung cancer: frequent involvement of 5q.
    Miura I; Graziano SL; Cheng JQ; Doyle LA; Testa JR
    Cancer Res; 1992 Mar; 52(5):1322-8. PubMed ID: 1346589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers.
    Conforti-Froes N; el-Zein R; Abdel-Rahman SZ; Zwischenberger JB; Au WW
    Mutat Res; 1997 Sep; 379(1):53-9. PubMed ID: 9330622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A parallel study of in vitro sensitivity to benzo[a]pyrene diol epoxide and bleomycin in lung carcinoma cases and controls.
    Wu X; Gu J; Amos CI; Jiang H; Hong WK; Spitz MR
    Cancer; 1998 Sep; 83(6):1118-27. PubMed ID: 9740076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No difference between smoking lung cancer patients and smoking controls in the frequency of spontaneous and mitomycin C induced chromosome aberrations in lymphocytes.
    Johansson M; Orndal C
    Hereditas; 1989; 111(1):61-3. PubMed ID: 2507480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer.
    Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletions of chromosome 5 in malignant myeloid disorders.
    Le Beau MM
    Cancer Surv; 1992; 15():143-59. PubMed ID: 1451109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.